ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

THTX Theratechnologies Inc

1.33
0.07 (5.56%)
15 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Theratechnologies Inc NASDAQ:THTX NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.07 5.56% 1.33 1.22 1.32 1.33 1.2286 1.28 21,028 22:12:39

Theratechnologies to Present at the B. Riley Securities Virtual Oncology Investor Conference

14/01/2021 2:49pm

GlobeNewswire Inc.


Theratechnologies (NASDAQ:THTX)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Theratechnologies Charts.

Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Paul Levesque, President and Chief Executive Officer and Dr. Christian Marsolais, Senior Vice President and Chief Medical Officer will present at the B. Riley Virtual Oncology Investor Conference on Wednesday, January 20, 2021 at 3:30 p.m. ET.     

To access the live virtual presentation, please visit the ‘News’ section of the Company’s website. A webcast replay will also be available approximately two hours after the presentation.        

About Theratechnologies Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR at www.sedar.com and on EDGAR at www.sec.gov.

For media inquiries:Denis BoucherVice-President, Communications and Corporate Affairs514-336-7800

For investor inquiries:Leah GibsonSenior Director, Investor Relationslgibson@theratech.com617-356-1009

1 Year Theratechnologies Chart

1 Year Theratechnologies Chart

1 Month Theratechnologies Chart

1 Month Theratechnologies Chart

Your Recent History

Delayed Upgrade Clock